Patents by Inventor Jessica Schwermann

Jessica Schwermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for diagnosis of high-affinity binders and marker sequences
    Patent number: 10060911
    Abstract: The present invention relates to a novel method for diagnosing high-affinity binders, in particular antibodies or autoantibodies, and the identification, characterization and selection of marker sequences and diagnostic use thereof, in particular in the form of a panel. The invention also relates to a singleplex assay in which the discovered selection of marker sequences is used in the form of a panel and high-affinity binders are detected using a single signal.
    Type: Grant
    Filed: August 18, 2012
    Date of Patent: August 28, 2018
    Assignee: Protagen Aktiengesellschaft
    Inventors: Stefan Müllner, Peter Schulz-Knappe, Angelika Lueking, Heike Göhler, Jessica Schwermann
  • MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS
    Publication number: 20150293120
    Abstract: The present invention relates to a novel method for identifying marker sequences for rheumatoid arthritis, the novel marker sequences discovered with the aid of the method, and the diagnostic use thereof. The invention also relates to diagnostic devices containing such marker sequences for rheumatoid arthritis, in particular a protein biochip or beads (pellets), and use thereof.
    Type: Application
    Filed: March 27, 2013
    Publication date: October 15, 2015
    Inventors: Angelika LÜKING, Peter SCHULZ-KNAPPE, Heike GÖHLER, Martin GAMER, Carmen THEEK, Daniel CHAMRAD, Anna TELAAR, Matthias VON DARL, Matthias SCHNEIDER, Jessica SCHWERMANN
  • Novel Method for Diagnosis of High-Affinity Binders and Marker Sequences
    Publication number: 20140309133
    Abstract: The present invention relates to a novel method for diagnosing high-affinity binders, in particular antibodies or autoantibodies, and the identification, characterisation and selection of marker sequences and diagnostic use thereof, in particular in the form of a panel. The invention also relates to a singleplex assay in which the discovered selection of marker sequences is used in the form of a panel and high-affinity binders are detected using a single signal.
    Type: Application
    Filed: August 18, 2012
    Publication date: October 16, 2014
    Applicant: Protagen Aktinegesellschaft
    Inventors: Stefan Müllner, Peter Schulz-Knappe, Angelika Lueking, Heike Göhler, Jessica Schwermann